West China School of Nursing, Sichuan University/Department of Nursing, West China Hospital, Sichuan University, PR China.
Patient Educ Couns. 2022 Nov;105(11):3213-3224. doi: 10.1016/j.pec.2022.07.008. Epub 2022 Jul 13.
Peer support is a common form of social support that is provided by individuals with the same disease, which is cost-effective and has enhanced health outcomes for patients. This study aimed to determine the effectiveness of peer support interventions on quality of life (QOL), depression, anxiety, and self-efficacy among patients with cancer.
A systematic search of seven databases were conducted from inception to January 2021. Studies were screened and assessed by two independent reviewers. Data synthesis was conducted using RevMan 5.3 software, and the standardized mean difference was used to calculate pooled effect sizes.
Seventeen studies were included in current review. The meta-analysis indicated significant beneficial effects of peer support on QOL (SMD = 0.48, 95% CI 0.21-0.75; p < 0.001), depression (SMD = -0.23, 95% CI -0.39 to -0.07; p = 0.005), anxiety (SMD = -0.24, 95% CI -0.45 to 0.03; p = 0.03), and self-efficacy (SMD = 0.22, 95% CI 0.03-0.42; p = 0.03) relative to controls. The subgroup analysis for QOL revealed that peer support delivered in the mixed mode contributed more than peer support delivered in the single mode (e.g., face-to-face or telephone).
Peer support has significant effects on improving QOL and self-efficacy as well as alleviating depression and anxiety among patients with cancer. Additional randomized controlled trials with rigorous design and larger sample sizes are warranted in the future.
Peer support programs might benefit patients with cancer and could be used as a complementary approach to traditional healthcare services during cancer rehabilitation.
同伴支持是一种常见的社会支持形式,由患有相同疾病的个体提供,具有成本效益,并能提高患者的健康结果。本研究旨在确定同伴支持干预对癌症患者生活质量(QOL)、抑郁、焦虑和自我效能的影响。
从创建到 2021 年 1 月,对七个数据库进行了系统检索。由两名独立评审员筛选和评估研究。使用 RevMan 5.3 软件进行数据综合,使用标准化均数差来计算合并效应量。
目前的综述纳入了 17 项研究。荟萃分析表明,同伴支持对 QOL(SMD = 0.48,95%CI 0.21-0.75;p<0.001)、抑郁(SMD = -0.23,95%CI -0.39 至 -0.07;p=0.005)、焦虑(SMD = -0.24,95%CI -0.45 至 0.03;p=0.03)和自我效能(SMD = 0.22,95%CI 0.03-0.42;p=0.03)的效果具有显著的有益作用,与对照组相比。QOL 的亚组分析表明,混合模式提供的同伴支持比单一模式(如面对面或电话)提供的同伴支持更有效。
同伴支持对改善癌症患者的生活质量和自我效能以及缓解抑郁和焦虑具有显著影响。未来需要进行更多设计严谨、样本量更大的随机对照试验。
同伴支持计划可能对癌症患者有益,可以作为癌症康复期间传统医疗保健服务的补充方法。